Risultati della ricerca - Daniel J. DeAngelo

Raffina i risultati
  1. 1
    Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia

    Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia di Shai Shimony, Daniel J. DeAngelo, Marlise R. Luskin

    Pubblicazione 2023
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    New Approaches to the Management of Adult Acute Lymphoblastic Leukemia

    New Approaches to the Management of Adult Acute Lymphoblastic Leukemia di Renato Bassan, Jean‐Pierre Bourquin, Daniel J. DeAngelo, Sabina Chiaretti

    Pubblicazione 2018
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Novel <i>SSBP2‐JAK2</i> fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre‐B acute lymphocytic leukemia

    Novel <i>SSBP2‐JAK2</i> fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre‐B acute lymphocytic leukemia di Jennifer L. Poitras, Paola Dal Cin, Jon C. Aster, Daniel J. DeAngelo, Cynthia C. Morton

    Pubblicazione 2008
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Invasive fungal disease in patients treated for newly diagnosed acute leukemia

    Invasive fungal disease in patients treated for newly diagnosed acute leukemia di Sarah P. Hammond, Francisco M. Marty, Julie M. Bryar, Daniel J. DeAngelo, Lindsey R. Baden

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Gefitinib induces myeloid differentiation of acute myeloid leukemia

    Gefitinib induces myeloid differentiation of acute myeloid leukemia di Kimberly Stegmaier, Steven M. Corsello, Kenneth N. Ross, Jenny Wong, Daniel J. DeAngelo, Todd R. Golub

    Pubblicazione 2005
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    SYK regulates mTOR signaling in AML

    SYK regulates mTOR signaling in AML di Julia Carnevale, Linda Ross, Alexandre Puissant, Versha Banerji, Richard M. Stone, Daniel J. DeAngelo, Kenneth N. Ross, Kimberly Stegmaier

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review

    Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review di Jorge E. Cortés, Jane F. Apperley, Daniel J. DeAngelo, Michael W. Deininger, Vamsi Kota, Philippe Rousselot, Carlo Gambacorti‐Passerini

    Pubblicazione 2018
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  8. 8
    The prevention and management of asparaginase‐related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH

    The prevention and management of asparaginase‐related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH di Jeffrey I. Zwicker, Tzu‐Fei Wang, Daniel J. DeAngelo, Mandy N. Lauw, Jean M. Connors, Anna Falanga, Malgorzata McMasters, Marc Carrier

    Pubblicazione 2020
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  9. 9
    The frequency and management of asparaginase‐related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute consortium protocols

    The frequency and management of asparaginase‐related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute consorti... di Rachael F. Grace, Suzanne E. Dahlberg, Donna Neuberg, Stephen E. Sallan, Jean M. Connors, Ellis J. Neufeld, Daniel J. DeAngelo, Lewis B. Silverman

    Pubblicazione 2011
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Impact of Conditioning Regimen Intensity on Outcome of Allogeneic Hematopoietic Cell Transplantation for Advanced Acute Myelogenous Leukemia and Myelodysplastic Syndrome

    Impact of Conditioning Regimen Intensity on Outcome of Allogeneic Hematopoietic Cell Transplantation for Advanced Acute Myelogenous Leukemia and Myelodysplastic Syndrome di Edwin P. Alyea, Haesook T. Kim, Vincent T. Ho, Corey Cutler, Daniel J. DeAngelo, Richard M. Stone, Jerome Ritz, Joseph H. Antin, Robert J. Soiffer

    Pubblicazione 2006
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia

    A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia di Aaron D. Schimmer, Azra Raza, Thomas H. Carter, David F. Claxton, Harry P. Erba, Daniel J. DeAngelo, Martin S. Tallman, Carolyn A. Goard, Gautam Borthakur

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML

    Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML di Thanh‐Trang Vo, Jeremy Ryan, Ruben D. Carrasco, Donna Neuberg, Derrick J. Rossi, Richard M. Stone, Daniel J. DeAngelo, Mark G. Frattini, Anthony Letai

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Clinical use of measurable residual disease in adult ALL: recommendations from a panel of U.S. experts

    Clinical use of measurable residual disease in adult ALL: recommendations from a panel of U.S. experts di Nicholas J. Short, Ibrahim Aldoss, Daniel J. DeAngelo, Marina Konopleva, Jessica T. Leonard, Aaron C. Logan, Jae H. Park, Bijal Shah, Wendy Stock, Elias Jabbour

    Pubblicazione 2025
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  14. 14
    Geriatric assessment in older patients with acute myeloid leukemia: A retrospective study of associated treatment and outcomes

    Geriatric assessment in older patients with acute myeloid leukemia: A retrospective study of associated treatment and outcomes di Alexander E. Sherman, Gabriela Motyckova, K. Rebecca Fega, Daniel J. DeAngelo, Gregory A. Abel, David P. Steensma, Martha Wadleigh, Richard M. Stone, Jane A. Driver

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic Transplantation

    Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic Transplantation di Philippe Armand, Haesook T. Kim, Daniel J. DeAngelo, Vincent T. Ho, Corey Cutler, Richard M. Stone, Jerome Ritz, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer

    Pubblicazione 2007
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)

    A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535) di Jeffrey E. Lancet, Anna Moseley, Steven Coutré, Daniel J. DeAngelo, Megan Othus, Martin S. Tallman, Mark R. Litzow, Rami S. Komrokji, Harry P. Erba, Frederick R. Appelbaum

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients

    Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients di Shai Shimony, Jacqueline S. Garcia, Julia Keating, Evan C. Chen, Marlise R. Luskin, Maximilian Stahl, Donna Neuberg, Daniel J. DeAngelo, Richard M. Stone, R. Coleman Lindsley

    Pubblicazione 2024
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801

    Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 198... di Daniel J. DeAngelo, Daohai Yu, Jeffrey L. Johnson, Steven Coutré, Richard M. Stone, Alison Stopeck, Jon P. Gockerman, Beverly S. Mitchell, Frederick R. Appelbaum, Richard A. Larson

    Pubblicazione 2007
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia

    Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia di Patrick Bhola, Brenton G. Mar, R. Coleman Lindsley, Jeremy Ryan, Leah J. Hogdal, Thanh Trang Vo, Daniel J. DeAngelo, Ilene Galinsky, Benjamin L. Ebert, Anthony Letai

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    A Phase I Study of CC-90002, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory (R/R) Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Final Results

    A Phase I Study of CC-90002, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory (R/R) Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Synd... di Amer M. Zeidan, Daniel J. DeAngelo, Jeanne Palmer, Christopher S. Seet, Martin S. Tallman, Xin Wei, Ying Fei Li, Nanette Hock, Michael R. Burgess, Kristen Hege, Wendy Stock

    Pubblicazione 2019
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: